Cargando…

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework

The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030. A key recommendation to reach this elimination goal is to reduce new infections by 90% and liver-related mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Popping, Stephanie, El-Sayed, Manal, Feld, Jordan, Hatzakis, Angelos, Hellard, Margaret, Lesi, Olufunmilayo, Ninburg, Michael, Ward, John, Boucher, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mediscript Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038125/
https://www.ncbi.nlm.nih.gov/pubmed/30050685
_version_ 1783338433139179520
author Popping, Stephanie
El-Sayed, Manal
Feld, Jordan
Hatzakis, Angelos
Hellard, Margaret
Lesi, Olufunmilayo
Ninburg, Michael
Ward, John
Boucher, Charles
author_facet Popping, Stephanie
El-Sayed, Manal
Feld, Jordan
Hatzakis, Angelos
Hellard, Margaret
Lesi, Olufunmilayo
Ninburg, Michael
Ward, John
Boucher, Charles
author_sort Popping, Stephanie
collection PubMed
description The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030. A key recommendation to reach this elimination goal is to reduce new infections by 90% and liver-related mortality by 65%. Countries are encouraged by the WHO to develop their own national elimination programmes in order to reach these goals. However, various gaps and challenges, such as the lack of high-quality epidemiological data, stigmatisation, and optimisation of the cascade of care, have arisen in the WHO strategic framework. The International Viral Hepatitis Elimination Meeting (IVHEM) has therefore established an expert panel made of clinicians, virologists, and public health specialists to discuss and address these challenges. This review highlights the outcome and proposed solutions to attempt at facilitating HCV elimination.
format Online
Article
Text
id pubmed-6038125
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mediscript Ltd
record_format MEDLINE/PubMed
spelling pubmed-60381252018-07-26 Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework Popping, Stephanie El-Sayed, Manal Feld, Jordan Hatzakis, Angelos Hellard, Margaret Lesi, Olufunmilayo Ninburg, Michael Ward, John Boucher, Charles J Virus Erad Conference Report The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030. A key recommendation to reach this elimination goal is to reduce new infections by 90% and liver-related mortality by 65%. Countries are encouraged by the WHO to develop their own national elimination programmes in order to reach these goals. However, various gaps and challenges, such as the lack of high-quality epidemiological data, stigmatisation, and optimisation of the cascade of care, have arisen in the WHO strategic framework. The International Viral Hepatitis Elimination Meeting (IVHEM) has therefore established an expert panel made of clinicians, virologists, and public health specialists to discuss and address these challenges. This review highlights the outcome and proposed solutions to attempt at facilitating HCV elimination. Mediscript Ltd 2018-07-01 /pmc/articles/PMC6038125/ /pubmed/30050685 Text en © 2018 The Authors. Journal of Virus Eradication published by Mediscript Ltd http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article published under the terms of a Creative Commons License.
spellingShingle Conference Report
Popping, Stephanie
El-Sayed, Manal
Feld, Jordan
Hatzakis, Angelos
Hellard, Margaret
Lesi, Olufunmilayo
Ninburg, Michael
Ward, John
Boucher, Charles
Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
title Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
title_full Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
title_fullStr Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
title_full_unstemmed Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
title_short Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
title_sort report from the international viral hepatitis elimination meeting (ivhem), 17–18 november 2017, amsterdam, the netherlands: gaps and challenges in the who 2030 hepatitis c elimination framework
topic Conference Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038125/
https://www.ncbi.nlm.nih.gov/pubmed/30050685
work_keys_str_mv AT poppingstephanie reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT elsayedmanal reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT feldjordan reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT hatzakisangelos reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT hellardmargaret reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT lesiolufunmilayo reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT ninburgmichael reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT wardjohn reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework
AT bouchercharles reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework